• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Zollar Alfred W

    4/23/25 4:21:23 PM ET
    $BK
    Major Banks
    Finance
    Get the next $BK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    ZOLLAR ALFRED W

    (Last) (First) (Middle)
    240 GREENWICH STREET

    (Street)
    NEW YORK NY 10286

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Bank of New York Mellon Corp [ BK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/21/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Deferred Stock Units (1) 04/21/2025 A 2,904 (2) (2) Common Stock 2,904 (3) 29,286.712 D
    Explanation of Responses:
    1. 1-for-1.
    2. The deferred stock units vest on the earlier of the date of the Corporation's 2026 Annual Meeting of Shareholders or one year from the grant date. Vested deferred stock units are payable in shares of Common Stock either in a lump sum or, if the grantee has so elected, in annual installments, in each case beginning the 30th day following the grantee's termination of service as a director of the Corporation. Deferred stock units pay dividend equivalents which are reinvented in additional deferred stock units.
    3. N/A.
    /s/ Jean Weng, Attorney-in-Fact 04/23/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BK

    DatePrice TargetRatingAnalyst
    5/28/2025$97.00Buy → Hold
    Truist
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/9/2024$82.00 → $94.00Equal-Weight → Overweight
    Morgan Stanley
    9/23/2024$66.00 → $80.00Hold → Buy
    Deutsche Bank
    7/15/2024$65.00Buy → Neutral
    Citigroup
    6/27/2024$60.00 → $70.00Mkt Perform → Outperform
    Keefe Bruyette
    1/30/2024$52.00 → $62.00Underweight → Equal-Weight
    Morgan Stanley
    12/18/2023$54.50Neutral → Overweight
    JP Morgan
    More analyst ratings

    $BK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BNY Mellon downgraded by Truist with a new price target

      Truist downgraded BNY Mellon from Buy to Hold and set a new price target of $97.00

      5/28/25 8:09:07 AM ET
      $BK
      Major Banks
      Finance
    • BNY Mellon downgraded by Wolfe Research

      Wolfe Research downgraded BNY Mellon from Outperform to Peer Perform

      1/3/25 7:17:32 AM ET
      $BK
      Major Banks
      Finance
    • BNY Mellon upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded BNY Mellon from Equal-Weight to Overweight and set a new price target of $94.00 from $82.00 previously

      12/9/24 7:29:51 AM ET
      $BK
      Major Banks
      Finance